Patient Understanding of LiverMultiScan
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT02877602|
Recruitment Status : Completed
First Posted : August 24, 2016
Last Update Posted : January 12, 2018
- Study Details
- Tabular View
- No Results Posted
- How to Read a Study Record
|Condition or disease||Intervention/treatment|
|Liver Diseases||Device: MRI Device: Transient Elastography|
|Study Type :||Observational|
|Actual Enrollment :||101 participants|
|Official Title:||Patient Understanding of LiverMultiScan|
|Actual Study Start Date :||February 2016|
|Actual Primary Completion Date :||December 2017|
|Actual Study Completion Date :||December 2017|
Experience of liver disease
This is defined as either those who have had direct experience of liver disease as sufferers, or the carers of those who have had liver disease. Each individual receives an MRI (LiverMultiScan), with many also receiving a FibroScan.
Other Name: LiverMultiScan
Device: Transient Elastography
Other Name: FibroScan
- Factors effecting MRI experience and understanding. [ Time Frame: Immediately (within 1 hour) after undergoing the MRI scan, and receiving results feedback. ]This will be analysed based on themes and trends emanating from answers within the focused interview and questionnaire following the scan, and results feedback.
- Comparison of MRI to ultrasound scan in terms of patient experience. [ Time Frame: Immediately (within 1 hour) after undergoing an MRI scan, and ultrasound (FibroScan) scan. ]This will be analysed based on themes and trends emanating from answers within the focused interview and questionnaire following the scan, and results feedback.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
|Ages Eligible for Study:||16 Years and older (Child, Adult, Older Adult)|
|Sexes Eligible for Study:||All|
|Accepts Healthy Volunteers:||Yes|
|Sampling Method:||Non-Probability Sample|
- Individuals with experience of liver disease.
- Individuals over the age of 16.
- Individuals willing to give informed consent for participation in the study.
- Individuals with any contraindication to magnetic resonance imaging.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02877602
|University of Oxford Centre for Clinical Magnetic Resonance Research (OCMR)|
|Oxford, Oxfordshire, United Kingdom, OX3 9DU|
|Principal Investigator:||Rajarshi Banerjee, BM BCh MRCP MSc DPhil||Perspectum Diagnostics|
|Other Study ID Numbers:||
|First Posted:||August 24, 2016 Key Record Dates|
|Last Update Posted:||January 12, 2018|
|Last Verified:||January 2018|
|Individual Participant Data (IPD) Sharing Statement:|
|Plan to Share IPD:||No|
Digestive System Diseases